Evaluation of dynamic lymphoscintigraphy and sentinel lymph‐node biopsy for detecting occult metastases in patients with penile squamous cell carcinoma
- 31 July 2007
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 100 (3) , 561-565
- https://doi.org/10.1111/j.1464-410x.2007.07013.x
Abstract
To evaluate the introduction of dynamic lymphoscintigraphy and sentinel lymph-node (SLN) biopsy (used to detect occult lymph node metastases in patients with penile cancer and clinically impalpable inguinal lymph nodes at presentation) at a UK tertiary referral centre for penile cancer.In all, 75 patients with penile squamous cell carcinoma of stage T1, grade > or = 2, and unilateral or bilateral impalpable groin nodes, were prospectively enrolled over a 2-year period. Patients underwent lymphoscintigraphy with (99m)technetium-labelled nanocolloid which was injected intradermally around the tumour or into the distal penile shaft skin. Four hours later, the SLN(s) were identified during surgery using a hand-held gamma-probe and intradermal injections with blue dye. Completion lymph node dissection was subsequently used in patients with tumour-positive SLNs.In all, 255 SLNs were removed from 143 groins; all excised nodes had taken up the radioactive marker, and the blue dye was evident in 87%. Eighteen of 75 (24%) patients and 21 of 143 groins (15%) had a tumour-positive SLN. All but one patient went on to completion lymph node dissection. Three of these 18 (17%) had further disease in other than SLNs. Six of 143 (4%) groins developed minor complications. One false-negative result was reported at a median (range) follow-up of 11 (2-24) months.This technique is feasible for managing penile cancer in a UK tertiary referral centre. The initial results suggest that it can accurately identify the SLN(s), which can then be removed for pathological review with minimal morbidity.Keywords
This publication has 23 references indexed in Scilit:
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI Journal of the National Cancer Institute, 2006
- Current status of dynamic lymphoscintigraphy and sentinel lymph‐node biopsy in urological malignanciesBJU International, 2005
- PATIENTS WITH PENILE CARCINOMA BENEFIT FROM IMMEDIATE RESECTION OF CLINICALLY OCCULT LYMPH NODE METASTASESJournal of Urology, 2005
- A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast CancerNew England Journal of Medicine, 2003
- Contemporary Morbidity From Lymphadenectomy For Penile Squamous Cell Carcinoma: The M.D. Anderson Cancer Center ExperienceJournal of Urology, 2002
- PROSPECTIVE VALIDATION OF THE ASSOCIATION OF LOCAL TUMOR STAGE AND GRADE AS A PREDICTIVE FACTOR FOR OCCULT LYMPH NODE MICROMETASTASIS IN PATIENTS WITH PENILE CARCINOMA AND CLINICALLY NEGATIVE INGUINAL LYMPH NODESJournal of Urology, 2001
- TUMOR STAGE, VASCULAR INVASION AND THE PERCENTAGE OF POORLY DIFFERENTIATED CANCER: INDEPENDENT PROGNOSTICATORS FOR INGUINAL LYMPH NODE METASTASIS IN PENILE SQUAMOUS CANCERJournal of Urology, 2001
- TUMOR STAGE, VASCULAR INVASION AND THE PERCENTAGE OF POORLY DIFFERENTIATED CANCER: INDEPENDENT PROGNOSTICATORS FOR INGUINAL LYMPH NODE METASTASIS IN PENILE SQUAMOUS CANCERJournal of Urology, 2001
- Sentinel Lymph Node Dissection for Penile CarcinomaJournal of Urology, 1995
- Contemporary Morbidity From Lymphadenectomy For Penile Squamous Cell Carcinoma: The M.D. Anderson Cancer Center ExperiencePublished by Wolters Kluwer Health